66 -2 (76) 2025 - Umarov B.Y., Khamdamov B.Z. - CHARACTERISTICS OF LONG-TERM NON-HEALING WOUNDS

CHARACTERISTICS OF LONG-TERM NON-HEALING WOUNDS

Umarov B.Y. - Bukhara State Medical Institute named after Abu Ali ibn Sino

Khamdamov B.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sino

Resume

The concentration of lysozyme in long-term non-healing wounds is characterized by a change in dynamics depending on the presence of generalization of infection in the form of an increase in production above the initial value. Such changes in lysozyme concentration are directly related to the presence of generalization of infection and can be used in predicting the course of the inflammatory process in patients with long-term non-healing wounds.

Key words: long-term non-healing wound, immunity, generalization of infection.

First page

350

Last page

359

For citation:Umarov B.Y., Khamdamov B.Z. - CHARACTERISTICS OF LONG-TERM NON-HEALING WOUNDS//New Day in Medicine 2(76)2025 350-359 https://https://newdayworldmedicine.com/en/new_day_medicine/2-76-2025

List of References

  1. Khramilin V.N. Modern aspects of local treatment of chronic wounds of the lower extremities in patients with diabetes mellitus. //Scientific and practical Medical Journal ENTS RAMS. 2015;4:26-30.
  2. Stone R.C. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers. //Sci. Transl. Med. 2017;9(371):eaaf8611.
  3. Burden of venous leg ulcers in the United States. / J.B. Rice, U. Desai, A.K. Cummings, et al. //J. Med. Econ. 2014;17:347-356.
  4. Driscoll P. Wound prevalence and wound management, 2012–2020. 2013. // Accessed on 14 September 2015. Available online: http://blog.mediligence.com/ 2013/01/29/wound-prevalence-and-wound- management-2012-2020/
  5. Garraud O., Hozzein W.N., Badr G. Wound healing: Time to look for intelligent, “natural” immunological approaches? //BMC Immunol. 2020;(18):23.
  6. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. /S.R. Nussbaum, M.J. Carter, C.E. Fife, et al. //Value Health. 2018;21:27-32.
  7. Olsson M., Jarbrink K., Divakar U. et al. The humanistic and economic burden of chronic wounds: A systematic review. //Wound Repair. Regen. 2019;27:114-125.
  8. Skin wound healing process and new emerging technologies for skin wound care and regeneration. / E.M. Tottoli, R. Dorati, I. Genta, et al. //Pharmaceutics. 2020;12:735.
  9. Immune regulation of skin wound healing: Mechanisms and novel therapeutic targets. / J. Larouche, S. Sheoran, K. Maruyama, et al. //Adv. Wound Care. 2018;7:209-231.
  10. Huang Y.Z., Gou M., Da L.C. et al. Mesenchymal stem cells for chronic wound healing: Current status of preclinical and clinical studies. //Tissue Eng. Part B. Rev. 2020;26:555-570.
  11. Goldberg S.R., Diegelmann R.F. What makes wounds chronic. //Surg. Clin. New Am. 2020;100:681-693.
  12. Kaur K., Singh A., Attri S. et al. Matrix metalloproteinases (MMPs) and diabetic foot: Pathophysiological findings and recent developments in their inhibitors of natural as well as synthetic origin. In The Eye and Foot in Diabetes. /K. Kaur, A. Singh, S. Attri, et al. //Intech. Open: London, UK, 2020.
  13. Nguyen T.T., Ding D., Wolter W.R. et al. Validation of matrix metalloproteinase-9 (MMP-9) as a novel target for the treatment of diabetic foot ulcers in humans and discovery of a potent and selective small-molecule MMP-9 inhibitor that accelerates healing. /T.T. Nguyen, D. Ding, W.R. Wolter, et al. //J. Med. Chem. 2018;61:8825-8837.
  14. High glucose activates ERK1/2 to stabilize AP1 and increase MMP9 expression in diabetic foot ulcers. /J. Lang, C. Yang, L. Liu, et al. //Exp. Cell Res. 2021; 112-550 pp.
  15. Khamdamov B.Z., Dekhkonov A.T. Prospects of using silver preparations for local treatment of wound infection //New day in medicine. Bukhara, 2021;2(34):141-145. https://newdayworldmedicine.com/en/article/228
  16. Khamdamov B.Z., Dekhkonov A.T., Khamdamov A.B., Akimbayeva K. A. Characteristics of the immune profile in wound infection in patients with diabetes mellitus //Problems of biology and medicine. - Samarkand, 2022;3(136):112-117.
  17. Dekhkonov A.T. Experimental development of diagnostic criteria for phases of the course of the wound process in experimental animals with diabetes mellitus. //Journal of MEDISINE and INNOVATIONS. 2022;4(8):97-112.
  18. Khamdamov B.Z. Dekhkonov A.T. Gaziev K.U. Khakimboyeva K.A. Characteristics of the Immune Profile in Wound Infection in Patients with Diabetes Mellitus //American Journal of Medical Sciences 2022;12 (4):432-436.
  19. Khamdamov B.Z. Dekhkonov A.T. Clinical and Labaratory Parameters Of The Wound Procees Complicated by the Systemic Inflammatory Response Syndrome in Patientes With Diabetes Mellitus. Tashkent medical academy. //Journal of Educational and Scientific Medicine. 2022;3(2):25-29.
  20. Khamdamov B.Z., Dekhkonov A.T. Development of diagnostic criteria for wound process phases in experemental animals with diabetes mellitus and systemic inflammatory reaction syndrome //Art of Medicine. International Medical Scientifc Journal. 2022 April;2(3):218-234.

    file

    download